Isabel Webster in withering put down of Jeremy Clarkson as weight loss jab ‘doesn’t seem to have worked’
Isabel Webster claims a weight loss drug 'hasn't worked' for the ex-Top Gear host
PA / GB NEWS
Isabel Webster has claimed weight loss jabs used by Boris Johnson and Jeremy Clarkson “haven’t worked” for the pair in a blistering takedown.
It comes as clamour for slimming drug Ozempic reaches a high enough level to prompt its “controlled and limited launch” by NHS England.
The drug, also known as semaglutide, is set to be prescribed via specialist NHS weight management services alongside a reduced calorie diet and exercise from 4th September.
The drug boasts a star studded list of users, including X owner Elon Musk, former Prime Minister Boris Johnson and ex-Top Gear host Jeremy Clarkson.
WATCH THE FULL DISCUSSION BELOW
While the latter of which claimed the injection has had a “tremendous” effect, GB News host Isabel Webster says it “doesn’t seemed to have worked” for the Grand Tour star.
Commentator Emily Carver commented that it is “rather amusing” that people like Jeremy Clarkson have taken the drug, given how certain figures in the US such as the Kardashians have made it a more “fashionable” treatment.
LATEST DEVELOPMENTS
Webster commented: “I don’t want to be mean, but it doesn’t seem to have worked for either of them [Boris Johnson and Jeremy Clarkson].”
Writing in his Sunday Times column, Clarkson spoke about how Ozempic suppressed his appetite and therefore helped his dieting efforts as a result.
“I can open the fridge, when there’s half a chicken and a juicy bottle of rosé, and I want neither”, he said.
“Of course, I’ll have to insert some balance in the future, or I’ll, you know, die. But for now it’s tremendous.
Boris Johnson has taken the Ozempic drug
PA“I never used to know what that Kate Moss was on about when she said that nothing tastes as good as skinny feels, but I think, on my new wonder drug, I soon will.”
Experts claim the drug has shown phenomenal rates of success, leading to stocks running dry worldwide.
Semaglutide was originally developed to treat type 2 diabetes, and was approved by the National Institute for Health and Care Excellence (NICE) in 2019.
Clarkson revealed that he paid £140 for an initial prescription, which is available for which is available for treating obesity as off label use in a private setting.
Wegovy is taken via a self-injection pen, and can be offered to patients trying to lose weight for a maximum of two years, under NICE rules.
Upon taking the medication, the body is signalled to release insulin, which helps move digested sugar from the blood into cells where it can be used for energy.
This means patients then feel full, and even sometimes repulsed by their favourite foods.
Ozempic has been shown to have some heavy side effects including mild or moderate nausea, acid reflux, cramping and diarrhoea, as well as constipation.
Researchers say these issues are short-lasting and resolve themselves.